復星醫藥(600196.SH):復星實業擬以1.24億美元出售相關資產
格隆匯3月13日丨復星醫藥(600196.SH)公佈,本公司控股子公司復星實業擬以現金12,408萬美元的對價向Calcite
Gem轉讓其所持有的標的公司(其主要資產系其通過其控股子公司NFH持有及運營的“和睦家”醫院和診所)940萬股普通股。本次交易完成後,本集團將不再持有標的公司的股權。
Calcite Gem 成立於2021年7月,註冊地爲開曼羣島。Calcite Gem 是一家投資控股公司,其由若幹華平投資(Warburg Pincus)旗下的投資基金全資擁有。截至本公告日期,Calcite Gem Investments Ltd 持有 Calcite Gem 100%股權。經合理查詢,截至本公告日期,Calcite Gem 具備本次交易的相關履約能力。
標的公司成立於2021年6月,註冊地爲開曼羣島,其聯合創始人和實際控制人爲樑錦鬆先生及吳啓楠先生。標的公司的主要資產系其通過控股子公司NFH持有及運營的“和睦家”醫院和診所。和睦家是一家中國領先的國際化醫療服務集團,在中國核心城市提供全生命週期的醫療保健服務。截至本公告日期,標的公司已發行股份總數爲142,531,510股。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.